(Q48590650)

13 February 2018

title

Clocinnamox dose-dependently antagonizes morphine-analgesia and [3H]DAMGO binding in rats. (English)

1 reference

13 February 2018

author name string

Paronis CA

series ordinal

1

1 reference

13 February 2018

Woods JH

series ordinal

2

1 reference

13 February 2018

language of work or name

English

0 references

publication date

1 October 1997

1 reference

13 February 2018

European Journal of Pharmacology

published in

1 reference

13 February 2018

volume

337

1 reference

13 February 2018

issue

1

1 reference

13 February 2018

page(s)

27-34

1 reference

13 February 2018

Effects of stress and beta-funal trexamine pretreatment on morphine analgesia and opioid binding in rats

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901296-X

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901296-X

The effect of the irreversible mu-opioid receptor antagonist clocinnamox on morphine potency, receptor binding and receptor mRNA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901296-X

Selectivity of ligand binding to opioid receptors in brain membranes from the rat, monkey and guinea pig.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901296-X

Long term kappa-opioid receptor blockade following nor-binaltorphimine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901296-X

Effects of intracerebroventricular β-funaltrexamine on μ and δ opioid receptors in the rat: dichotomy between binding and antinociception

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901296-X

Opioid-receptor mRNA expression in the rat CNS: anatomical and functional implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901296-X

Selective loss of delta opioid analgesia and binding by antisense oligodeoxynucleotides to a delta opioid receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901296-X

In vivo apparent pA2 analysis in rats treated with either clocinnamox or morphine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901296-X

Pharmacological profiles of beta-funaltrexamine (beta-FNA) and beta-chlornaltrexamine (beta-CNA) on the mouse vas deferens preparation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901296-X

Opioid receptor binding characteristics of the non-equilibrium mu antagonist, beta-funaltrexamine (beta-FNA).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2901296-X

10.1016/S0014-2999(97)01296-X

7 January 2021

Identifiers

DOI

1 reference

13 February 2018

1 reference

13 February 2018